0000950170-24-065983.txt : 20240529
0000950170-24-065983.hdr.sgml : 20240529
20240529163320
ACCESSION NUMBER: 0000950170-24-065983
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Ryan Alexander
CENTRAL INDEX KEY: 0002007219
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41947
FILM NUMBER: 24998892
MAIL ADDRESS:
STREET 1: C/O KYVERNA THERAPEUTICS, INC.
STREET 2: 5980 HORTON ST., SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kyverna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001994702
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831365441
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5106268331
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
ownership.xml
4
X0508
4
2024-05-28
0001994702
Kyverna Therapeutics, Inc.
KYTX
0002007219
Jones Ryan Alexander
C/O KYVERNA THERAPEUTICS, INC.
5980 HORTON ST., STE 550
EMERYVILLE
CA
94608
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-05-28
4
M
false
10870
0.73
A
36804
D
Common Stock
2024-05-28
4
M
false
7146
0.73
A
43950
D
Stock Option (Right to Buy)
0.73
2024-05-28
4
M
false
10870
0
D
Common Stock
10870
0
D
Stock Option (Right to Buy)
0.73
2024-05-28
4
M
false
7146
0
D
Common Stock
7146
2192
D
25% of the original number of shares subject to the option vested on April 15, 2021, and 1/48th of the original number of shares subject to the option vested in monthly installments thereafter.
25% of the original number of shares subject to the option vested on January 1, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
By: /s/ Ryan Jones
2024-05-29